131 related articles for article (PubMed ID: 8908286)
1. Histological effect of intranodal injection of the streptococcal preparation OK-432 for cervical lymph node metastases of malignant head and neck tumors.
Suzuki K; Tsuge I; Ito Y; Kunii H; Baba S
Acta Otolaryngol Suppl; 1996; 525():125-8. PubMed ID: 8908286
[TBL] [Abstract][Full Text] [Related]
2. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck.
Vauterin TJ; Veness MJ; Morgan GJ; Poulsen MG; O'Brien CJ
Head Neck; 2006 Sep; 28(9):785-91. PubMed ID: 16783833
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical studies on local antitumor effects of streptococcal immunopotentiator, OK-432, in human solid malignant tumors.
Sugenoya A; Usuda N; Adachi W; Kaneko G; Nagata T; Iida F
Arch Pathol Lab Med; 1988 May; 112(5):545-9. PubMed ID: 3282486
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological study on patterns of cervical lymph node metastases from squamous cell carcinomas (SCC) of the head and neck].
Li X; Li L; Wei W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):206-9. PubMed ID: 9642343
[TBL] [Abstract][Full Text] [Related]
5. [Tissue and serum levels of 5-FU in the patients with head and neck malignant tumors--influence of a streptococcal preparation OK-432].
Suzuki K; Itaya S; Tsuge I; Matsuda T; Motai H; Kobayashi T; Shimada J; Baba S
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1349-54. PubMed ID: 8346933
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
[TBL] [Abstract][Full Text] [Related]
7. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
[TBL] [Abstract][Full Text] [Related]
8. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck.
Rhee D; Wenig BM; Smith RV
Laryngoscope; 2002 Nov; 112(11):1970-4. PubMed ID: 12439164
[TBL] [Abstract][Full Text] [Related]
9. Inhalation therapy using a streptococcal preparation (OK-432) against bronchioloalveolar carcinoma of the lung.
Yano T; Ichinose Y; Yokoyama H; Fukuyama Y; Sugio K; Sugimachi K
Anticancer Res; 1999; 19(6C):5511-4. PubMed ID: 10697608
[TBL] [Abstract][Full Text] [Related]
10. Pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck.
Barzilai G; Greenberg E; Cohen-Kerem R; Doweck I
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):852-6. PubMed ID: 15944554
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
[TBL] [Abstract][Full Text] [Related]
12. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
13. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
14. Metastasis to the submandibular gland in head and neck carcinomas.
Spiegel JH; Brys AK; Bhakti A; Singer MI
Head Neck; 2004 Dec; 26(12):1064-8. PubMed ID: 15459920
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
Tao L; Lefèvre M; Callard P; Périé S; Bernaudin JF; St Guily JL
Otolaryngol Head Neck Surg; 2006 Sep; 135(3):445-50. PubMed ID: 16949980
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
17. Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer.
Villaret AB; Piazza C; Peretti G; Calabrese L; Ansarin M; Chiesa F; Pellini R; Spriano G; Nicolai P
Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):897-903. PubMed ID: 17875856
[TBL] [Abstract][Full Text] [Related]
18. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
[TBL] [Abstract][Full Text] [Related]
19. An extended use of the sentinel node in head and neck squamous cell carcinoma: results of a prospective study of 100 patients.
Barzan L; Sulfaro S; Alberti F; Politi D; Pin M; Savignano MG; Marus W; Zarcone O; Spaziante R
Acta Otorhinolaryngol Ital; 2004 Jun; 24(3):145-9. PubMed ID: 15584585
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
